World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
78
Citations
21577
World Ranking
1755
National Ranking
866

Medicine

D-Index
78
Citations
21577
World Ranking
18069
National Ranking
9007

Walid Heneine publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Walid Heneine sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 267 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Walid Heneine D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Walid Heneine sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 78 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Walid Heneine is affiliated with the Centers for Disease Control and Prevention in the United States. Their research primarily focuses on infectious diseases with an emphasis on HIV/AIDS, particularly in the development of drug treatments, interventions, and epidemiological studies.

The scientist has contributed extensively to the fields of medicine and immunology and microbiology. Their work spans several subfields, including infectious diseases, virology, epidemiology, microbiology, and physiology.

Research topics frequently explored by Walid Heneine include:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV/AIDS Drug Development and Treatment
  • HIV, Drug Use, Sexual Risk
  • Reproductive Tract Infections Research
  • Syphilis Diagnosis and Treatment
  • T-cell and Retrovirus Studies

Walid Heneine has collaborated frequently with a number of coauthors, including:

  • J. Gerardo García-Lerma
  • Chuong Dinh
  • James Mitchell
  • Angela Holder
  • Charles Dobard

The scientist's work has appeared in several notable publication venues, with the highest number of articles in EBioMedicine, followed by UNC Libraries, Nature Communications, Journal of Antimicrobial Chemotherapy, and AIDS.

Some of the recent papers authored or coauthored by Walid Heneine include:

  • Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014-2018 (2021), Clinical Infectious Diseases
  • Single Oral Dose for HIV Pre or Post-Exposure Prophylaxis: User Desirability and Biological Efficacy in Macaques (2020), EBioMedicine
  • Ultra-long-acting In-situ Forming Implants With Cabotegravir Protect Female Macaques Against Rectal SHIV Infection (2023), Nature Communications
  • Single Dose Topical Inserts Containing Tenofovir Alafenamide Fumarate and Elvitegravir Provide Pre- and Post-Exposure Protection Against Vaginal SHIV Infection in Macaques (2022), EBioMedicine
  • Pharmacokinetics of Single Dose Doxycycline in the Rectum, Vagina, and Urethra: Implications for Prevention of Bacterial Sexually Transmitted Infections (2024), EBioMedicine

This body of research reflects a focus on both biological efficacy of HIV prevention methods and pharmacokinetics relevant to sexually transmitted infections. The combination of laboratory-based studies and epidemiological approaches underscores a comprehensive approach to addressing infectious diseases within the context of public health.

Best Publications

  • Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis.

    Adelisa L Panlilio;Denise M Cardo;Lisa A Grohskopf;Walid Heneine

  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes

  • Search for Cross-Species Transmission of Porcine Endogenous Retrovirus in Patients Treated with Living Pig Tissue

    Khazal Paradis;Gillian Langford;Zhifeng Long;Walid Heneine

  • Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters

    Nathan D. Wolfe;Walid Heneine;Jean K. Carr;Albert D. Garcia

  • Naturally acquired simian retrovirus infections in central African hunters

    Nathan D Wolfe;William M Switzer;Jean K Carr;Vinod B Bhullar

  • Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy

    Jeffrey A Johnson;Jin-Fen Li;Xierong Wei;Jonathan Lipscomb

  • No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts

    Walid Heneine;Annika Tibell;William M Switzer;Paul Sandstrom

  • Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

    J. Gerardo García-Lerma;Ron A. Otten;Shoukat H. Qari;Eddie Jackson

  • Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis

    David T. Kuhar;David K. Henderson;Kimberly A. Struble;Walid Heneine

  • Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: Implications for treatment and postexposure prophylaxis

    Myriam Witvrouw;Christophe Pannecouque;William M Switzer;Thomas M Folks

  • The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.

    Hillard S. Weinstock;Irum Zaidi;Walid Heneine;Diane Bennett

  • Identification of a Human Population Infected With Simian Foamy Viruses

    Walid Heneine;William M. Switzer;Paul Sandstrom;Jennifer Brown

  • Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.

    William Wheeler;Rebecca Ziebell;Helena Zabina;Danuta Pieniazek

  • Ancient co-speciation of simian foamy viruses and primates.

    William M. Switzer;Marco Salemi;Vedapuri Shanmugam;Feng Gao

  • 1970s and ‘Patient 0’ HIV-1 genomes illuminate early HIV/AIDS history in North America

    Michael Worobey;Thomas D. Watts;Richard A. McKay;Marc A. Suchard

  • Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.

    Urvi M. Parikh;Charles Dobard;Sunita Sharma;Mian Er Cong

  • Emergence of Drug-Resistant HIV-1 after Intrapartum Administration of Single-Dose Nevirapine Is Substantially Underestimated

    Jeffrey A. Johnson;Jin Fen Li;Lynn Morris;Neil Martinson

  • Multiple Groups of Novel Retroviral Genomes in Pigs and Related Species

    Clive Patience;William M. Switzer;Yasuhiro Takeuchi;David J. Griffiths

  • Frequent Simian Foamy Virus Infection in Persons Occupationally Exposed to Nonhuman Primates

    William M. Switzer;Vinod Bhullar;Vedapuri Shanmugam;Mian Er Cong

  • Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection

    J. Gerardo García-Lerma;Mian Er Cong;James Mitchell;Ae S. Youngpairoj

  • Brief report: infection of a laboratory worker with simian immunodeficiency virus.

    Rima F. Khabbaz;Walid Heneine;J. Richard George;Bharat Parekh

  • Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons

    J G Garcia-Lerma;S Nidtha;K Blumoff;H Weinstock

  • Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States.

    William M Switzer;Hongwei Jia;Oliver Hohn;HaoQiang Zheng

Frequent Co-Authors

William M. Switzer
William M. Switzer Centers for Disease Control and Prevention
Thomas M. Folks
Thomas M. Folks Centers for Disease Control and Prevention
Debra L. Hanson
Debra L. Hanson Centers for Disease Control and Prevention
Paul Sandstrom
Paul Sandstrom Public Health Agency of Canada
Nathan D. Wolfe
Nathan D. Wolfe Global Viral
Donald S. Burke
Donald S. Burke University of Pittsburgh
Jonathan E. Kaplan
Jonathan E. Kaplan Centers for Disease Control and Prevention
Bharat Parekh
Bharat Parekh Centers for Disease Control and Prevention
Vincent Soriano
Vincent Soriano Universidad Internacional De La Rioja
Renu B. Lal
Renu B. Lal Centers for Disease Control and Prevention

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Many students consider advancing to specialized nursing roles, such as becoming a psychiatric nurse practitioner. Affordable options are available through programs like the cheap psych np programs, which combine accessibility with quality education.

Understanding earning potential is also crucial. For nurse practitioners, salaries can vary widely across the USA. Reviewing the dnp salary landscape helps aspiring professionals make informed decisions about where to study and work.

For those already pursuing a Family Nurse Practitioner (FNP) path, transitioning to more acute care roles is a natural step. Resources on how to obtain fnp to acute care certification provide guidance to expand clinical expertise and improve job prospects.

Accelerated programs designed for working nurses or students with previous degrees offer an efficient route to becoming a nurse practitioner. Choosing from the nurse practitioner accelerated program options can significantly shorten time to degree completion, making them a valuable consideration for many.

Best Scientists Citing Walid Heneine

Trending Scientists

Recently Published Articles